Waldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging. The company was founded in 1988 and is based in White Plains, New York.
Revenue of Waldencast plc (WALD)
Revenue in 2024 (TTM): $218.14 M
According to Waldencast plc's latest financial reports the company's current revenue (TTM) is $218.14 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Waldencast plc
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2024 | $218.14 M | $141.58 M | $-33,539,000 | $-112,943,000 | $-89,981,000 |
| 2023 | $166.13 M | $39.44 M | $-99,250,000 | $-147,304,000 | $-116,624,000 |
| 2022 | $142.47 M | $87.44 M | $15.05 M | $-9,974,000 | $-19,576,000 |
| 2021 | $94.43 M | $65.33 M | $13.94 M | $-5,764,000 | $-2,370,000 |